N-[2-(diethylamino)ethyl]-2-methoxy-5-methylsulfonylbenzamide
Tiapride is an atypical antipsychotic from the group of benzamides, primarily acting through selective blockade of dopamine D2 and D3 receptors. It is mainly used for the treatment of psychotic disorders and certain movement disorders. The substance has a moderate side effect profile, with extrapyramidal symptoms possible. Tiapride exhibits a sedative effect and influences the central nervous system through dopaminergic modulation.
Translation in progress
This section is currently being translated. Content will be available soon.
View German version →Receptor Targets
Mechanism of Action
Designations
IUPAC: N-[2-(diethylamino)ethyl]-5-mesyl-2-methoxy-benzamide
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Synapedia Evidence
Effects & Pharmacology — Translation in progress
This section is being translated. Content is available in German.
View in German →Total duration 12-24 hours
Peak
3-6 hours
Onset
1-2 hours
Total duration
12-24 hours
After effects
Variable
Start low. Individual sensitivity varies.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Summary
Mögliche Nebenwirkungen wie Sedierung, Schwindel und extrapyramidale Symptome.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.